DK645289D0 - Phosphonsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse - Google Patents

Phosphonsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse

Info

Publication number
DK645289D0
DK645289D0 DK645289A DK645289A DK645289D0 DK 645289 D0 DK645289 D0 DK 645289D0 DK 645289 A DK645289 A DK 645289A DK 645289 A DK645289 A DK 645289A DK 645289 D0 DK645289 D0 DK 645289D0
Authority
DK
Denmark
Prior art keywords
phosphonic acid
pharmaceutical agents
agents containing
substituted steroids
absent
Prior art date
Application number
DK645289A
Other languages
English (en)
Other versions
DK645289A (da
Inventor
Dennis Alan Holt
Mark Alan Levy
Brian Walter Metcalf
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of DK645289D0 publication Critical patent/DK645289D0/da
Publication of DK645289A publication Critical patent/DK645289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/002—Expansion of ring A by one atom, e.g. A homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK645289A 1988-12-23 1989-12-19 Phosphonsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse DK645289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/290,211 US4946834A (en) 1988-12-23 1988-12-23 Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors

Publications (2)

Publication Number Publication Date
DK645289D0 true DK645289D0 (da) 1989-12-19
DK645289A DK645289A (da) 1990-06-24

Family

ID=23114990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645289A DK645289A (da) 1988-12-23 1989-12-19 Phosphonsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse

Country Status (12)

Country Link
US (1) US4946834A (da)
EP (1) EP0375351B1 (da)
JP (1) JPH02215795A (da)
AT (1) ATE110736T1 (da)
AU (1) AU631387B2 (da)
CA (1) CA2005165A1 (da)
DE (1) DE68917885T2 (da)
DK (1) DK645289A (da)
ES (1) ES2058561T3 (da)
IE (1) IE65517B1 (da)
PT (1) PT92722A (da)
ZA (1) ZA899670B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4970204A (en) * 1989-08-23 1990-11-13 Smithkline Beecham Corporation 3-substituted nitro-steroid derivatives as 5-α-reductase inhibitors
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
IL104601A0 (en) * 1992-02-07 1993-07-08 Smithkline Beecham Corp Process for the preparation of steroidal dienes
EP0725074A3 (en) * 1992-04-20 1996-11-20 Sankyo Co Compounds for use, therefore, intermediates for the preparation of androst-3,5-diene-3-carboxy derivatives
RU2141967C1 (ru) * 1992-05-21 1999-11-27 Андорешерш Инк. ИНГИБИТОРЫ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИНГИБИРОВАНИЯ АКТИВНОСТИ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5637310A (en) * 1993-12-20 1997-06-10 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
EP0754701B1 (en) * 1994-04-04 1998-08-12 Meiji Milk Products Company Limited Novel progesterone compound and use thereof
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider
CA1252778A (en) * 1983-08-25 1989-04-18 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Steroids
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
AU4700389A (en) 1990-06-28
DE68917885D1 (de) 1994-10-06
ES2058561T3 (es) 1994-11-01
US4946834A (en) 1990-08-07
ATE110736T1 (de) 1994-09-15
EP0375351A1 (en) 1990-06-27
AU631387B2 (en) 1992-11-26
DK645289A (da) 1990-06-24
JPH02215795A (ja) 1990-08-28
PT92722A (pt) 1990-06-29
EP0375351B1 (en) 1994-08-31
DE68917885T2 (de) 1994-12-22
ZA899670B (en) 1990-11-28
CA2005165A1 (en) 1990-06-23
IE894110L (en) 1990-06-23
IE65517B1 (en) 1995-11-01

Similar Documents

Publication Publication Date Title
DK645389A (da) Phosphinsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse
DK645289D0 (da) Phosphonsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse
DK196691A (da) Steroid-5-alfa-reduktaseinhibitorer
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
IE881269L (en) Steroids
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
FI871143A (fi) Nya derivater av karboxylsyra, foerfarande foer framstaellning av dessa, deras anvaendning samt laekemedel som innehaoller dessa foereningar.
BR0015939A (pt) Sistemas terapêuticos transdérmicos com estabilidade aperfeiçoada e um processo para a sua preparação
FI913556A (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
GB2115409B (en) Novel crystal modifications of (+)-catechin
DK319484A (da) Imidazol-2-ylthioalkansyrer, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
HUP9802206A1 (hu) Thalidomid intravénás adagolási formája immunológiai megbetegedések gyógyításához
ATE90355T1 (de) Weiche steroide mit anti-entzuendungswirkung.
DK382185A (da) Umaettede 10-substituerede steroider samt fremgangsmaade til deres fremstilling
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment